2016
A Pooled Analysis of Reproductive Factors, Exogenous Hormone Use, and Risk of Multiple Myeloma among Women in the International Multiple Myeloma Consortium
COSTAS, Laura; Brice H. LAMBERT; Brenda M. BIRMANN; Kirsten B. MOYSICH; Anneclaire J. De ROOS et. al.Basic information
Original name
A Pooled Analysis of Reproductive Factors, Exogenous Hormone Use, and Risk of Multiple Myeloma among Women in the International Multiple Myeloma Consortium
Authors
COSTAS, Laura (724 Spain); Brice H. LAMBERT (840 United States of America); Brenda M. BIRMANN (840 United States of America); Kirsten B. MOYSICH (840 United States of America); Anneclaire J. De ROOS (840 United States of America); Jonathan N. HOFMANN (840 United States of America); Dalsu BARIS (840 United States of America); Sophia S. WANG (840 United States of America); Nicola J. CAMP (840 United States of America); Guido TRICOT (840 United States of America); Djordje ATANACKOVIC (840 United States of America); Paul BRENNAN (250 France); Pierluigi COCCO (380 Italy); Alexandra NIETERS (276 Germany); Nikolaus BECKER (276 Germany); Marc MAYNADIÉ (250 France); Lenka FORETOVÁ (203 Czech Republic, guarantor, belonging to the institution); Paolo BOFFETTA (840 United States of America); Anthony STAINES (372 Ireland); Elisabeth E. BROWN (840 United States of America) and Silvia de SANJOSÉ (724 Spain)
Edition
Cancer Epidemiology Biomarkers & Prevention, Philadelphia, American Association for Cancer Research Inc. 2016, 1055-9965
Other information
Language
English
Type of outcome
Article in a journal
Field of Study
30200 3.2 Clinical medicine
Country of publisher
United States of America
Confidentiality degree
is not subject to a state or trade secret
Impact factor
Impact factor: 4.142
RIV identification code
RIV/00216224:14110/16:00090429
Organization unit
Faculty of Medicine
UT WoS
000372171400029
EID Scopus
2-s2.0-84955294772
Keywords in English
LYMPHOMAS; COHORT; HEALTH
Tags
Tags
International impact, Reviewed
Changed: 4/8/2016 15:15, Ing. Mgr. Věra Pospíšilíková
Abstract
In the original language
Background: Female sex hormones are known to have immunomodulatory effects. Therefore, reproductive factors and exogenous hormone use could influence the risk of multiple myeloma in women. However, the role of hormonal factors in multiple myeloma etiology remains unclear because previous investigations were underpowered to detect modest associations. Methods: We conducted a pooled analysis of seven case-control studies included in the International Multiple Myeloma Consortium, with individual data on reproductive factors and exogenous hormone use from 1,072 female cases and 3,541 female controls. Study-specific odds ratios and corresponding 95% confidence intervals (CI) were estimated using logistic regression and pooled analyses were conducted using random effects meta-analyses. Results: Multiple myeloma was not associated with reproductive factors, including ever parous [OR = 0.92; 95% confidence interval (CI), 0.68-1.25], or with hormonal contraception use (OR = 1.04; 95% CI, 0.80-1.36). Postmenopausal hormone therapy users had nonsignificantly reduced risks of multiple myeloma compared with never users, but this association differed across centers (OR = 0.65; 95% CI, 0.37-1.15, I-2 = 76.0%, P-heterogeneity = 0.01). Conclusions: These data do not support a role for reproductive factors or exogenous hormones in myelomagenesis. Impact: Incidence rates of multiple myeloma are higher in men than in women, and sex hormones could influence this pattern. Associations with reproductive factors and exogenous hormone use were inconclusive despite our large sample size, suggesting that female sex hormones may not play a significant role in multiple myeloma etiology.